APOL1 Risk Variants Impair Multiple Mitochondrial Pathways in a Metabolomics Analysis

Kidney360. 2020 Sep 30;1(12):1353-1362. doi: 10.34067/KID.0003592020. eCollection 2020 Dec 31.

Abstract

Background: Kidney risk variants (KRVs) in the APOL1 gene are associated with mitochondrial dysfunction. However, the molecular spectrum of metabolites affected by the G1 and G2 KRVs, and the downstream mitochondrial pathways they affect, remain unknown.

Methods: We performed a metabolomics analysis using HEK293 Tet-on cells conditionally expressing APOL1 G0, G1, and G2 KRVs to determine the patterns of metabolites and pathways potentially involved in nephropathy. The Welch two-sample t test, matched-pairs t test, and two-way repeated measures ANOVA were used to identify differential metabolites. Random forest, a supervised classification algorithm that uses an ensemble of decision trees, and the mean-decrease-accuracy metric were applied to prioritize top metabolites.

Results: Alterations in the tricarboxylic acid cycle, increased fatty acid oxidation, and compromised redox homeostasis were the major pathways affected by overexpression of APOL1 KRVs.

Conclusions: Impairment of mitochondrial membrane respiratory chain complex I appeared to account for critical metabolic consequences of APOL1 KRVs. This finding supports depletion of the mitochondrial membrane potential, as has been reported.

Keywords: APOL1; African Americans; CKD; FSGS; chronic kidney disease; genetics; kidney; metabolomics; mitochondria.

MeSH terms

  • Apolipoprotein L1* / genetics
  • Genetic Predisposition to Disease*
  • HEK293 Cells
  • Humans
  • Metabolomics
  • Mitochondria / genetics

Substances

  • APOL1 protein, human
  • Apolipoprotein L1